Dr Reddy's Laboratories launches Regadenoson injection in US market
The injection is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. In a separate filing, Dr Reddy's said it has issued a Form 483 with one observation by the USFDA after a routine GMP inspection at its API manufacturing facility (CTO 1) in Bollaram, Hyderabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2023 Category: Pharmaceuticals Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA advierte de riesgo poco com ún pero grave de ataque al corazón y muerte con los medicamentos Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco
El 11 de noviembre, 2013, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) está advirtiéndole a los profesionales de la salud del riesgo poco común pero grave de ataque al corazón y muerte, con el uso de los agentes Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 2, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
PET MPI identifies heart attack risk in diabetics
Irregular results on a PET myocardial perfusion imaging (MPI) stress test imply...Read more on AuntMinnie.comRelated Reading:
Cardiac hybrid imaging predicts adverse cardiac events
SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET
Lantheus touts study on cardiac radiotracer
Regadenoson with Rb-82 PET MPI helps detect obstructive CAD
PET MPI with flurpiridaz F-18 tops SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2019 Category: Radiology Source Type: news
Drug shortage puts PET, SPECT stress to the test
Nuclear medicine facilities are again relying on their improvisational skills...Read more on AuntMinnie.comRelated Reading:
FDA warns of risks with Lexiscan, Adenoscan stress agents
Regadenoson with Rb-82 PET MPI helps detect obstructive CAD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 3, 2018 Category: Radiology Source Type: news
Lexiscan (Regadenoson Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 27, 2017 Category: Drugs & Pharmacology Source Type: news
GE purchases expanded rights to Rapiscan stress agent
GE Healthcare's Life Sciences unit has purchased exclusive rights to produce...Read more on AuntMinnie.comRelated Reading:
Boston Children's, GE partner on pediatric diseases
FDA clears GE MBI biopsy accessory
Dilon, GE ink distribution deal
GE Healthcare sees strong Q3 growth in profit, revenue
FDA warns of risks with Lexiscan, Adenoscan stress agents (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2017 Category: Radiology Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA advierte de riesgo poco común pero grave de ataque al corazón y muerte con los medicamentos Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco
El 11 de noviembre, 2013, La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) está advirtiéndole a los profesionales de la salud del riesgo poco común pero grave de ataque al corazón y muerte, con el uso de los agentes Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 1, 2016 Category: Drugs & Pharmacology Source Type: news
FDA Warns About Risk for MI, Death with Cardiac Nuclear Stress Test Agents (FREE)
By Amy Orciari Herman
Cardiac nuclear stress test agents — namely, regadenoson (Lexiscan) and adenosine (Adenoscan) — pose a "rare but serious" … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 21, 2013 Category: Primary Care Source Type: news
FDA warns of risks with Lexiscan, Adenoscan stress agents
The U.S. Food and Drug Administration on November 20 issued a warning about (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 21, 2013 Category: Radiology Source Type: news
Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication - Rare but Serious Risk of Heart Attack and Death
Cases of myocardial infarction and death have occurred following the administration of Lexiscan (regadenoson) injection or Adenoscan (adenosine) infusion. (Source: FDA MedWatch)
Source: FDA MedWatch - November 20, 2013 Category: American Health Source Type: news
FDA Issues Warning on Regadenoson, AdenosineFDA Issues Warning on Regadenoson, Adenosine
Clinicians should avoid using these imaging agents for cardiac nuclear stress tests of patients with unstable angina or cardiovascular instability lest their odds of a fatal heart attack increase. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 20, 2013 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Cardio Imaging Agent Placed on FDA Watch ListCardio Imaging Agent Placed on FDA Watch List
The agency received reports possibly linking regadenoson to fatal myocardial infarctions. The FDA will try to determine whether there is a causal relationship. News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2013 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
Stress Test Agents Equal for Predicting CAD Risk (CME/CE)
CHICAGO (MedPage Today) -- Stress tests done with the newer vasodilator regadenoson (Lexiscan) have the same predictive power for coronary artery disease as conventional adenosine (Adenoscan), a study affirmed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 29, 2013 Category: Cardiology Source Type: news
Regadenoson with Rb-82 PET MPI helps detect obstructive CAD
The pharmacological stress agent regadenoson with rubidium-82 (Rb-82) PET myocardial (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2013 Category: Radiology Source Type: news
Stress CT Perfusion Matches SPECT for Myocardial IschemiaStress CT Perfusion Matches SPECT for Myocardial Ischemia
In stress testing using regadenoson, CT perfusion imaging resulted in a similar ability to detect or rule out myocardial ischemia, compared with the reference method, regadenoson stress testing and single-photon-emission CT imaging, in a phase 2 trial. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
